BioMarin Pharmaceutical Inc
BMRN· Nasdaq
BMRNBioMarin Pharmaceutical Inc
Filed Oct 31, 2011 · 10-Q · 31 days after period end · 0001193125-11-288430
| Metric | Q3 2011 | Q3 2010 | Q3 2009 |
|---|---|---|---|
| Revenue | $113.43M | $97.75M | $80.81M |
| Net Income | -$17.65M | $217.33M | $6.64M |
| EPS Diluted | -$0.16 | $1.68 | $0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Oct 31, 2011 · 31 d after period end
